Bernhard Hess

Summary

Country: Switzerland

Publications

  1. ncbi Determinants of persistence in hypertensive patients treated with irbesartan: results of a postmarketing survey
    Michel Burnier
    Service de Nephrologie, CHUV, Lausanne, Switzerland
    BMC Cardiovasc Disord 5:13. 2005
  2. ncbi Nutritional aspects of stone disease
    Bernhard Hess
    Departments of Internal Medicine and Nephrology, Hospital Zimmerberg, CH 8820 Waedenswil, Switzerland
    Endocrinol Metab Clin North Am 31:1017-30, ix-x. 2002
  3. ncbi [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi]
    B Hess
    Medizinische Klinik, Spital Zimmerberg, Wädenswil
    Ther Umsch 60:79-87. 2003
  4. ncbi Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function
    Markus Jaggi
    Renal Stone Clinic and Stone Research Laboratory, Policlinic of Internal Medicine, University Hospital, Berne, Switzerland
    Urol Res 35:55-62. 2007
  5. ncbi Acid-base metabolism: implications for kidney stones formation
    Bernhard Hess
    Internal Medicine and Nephrology, Klinik Im Park, Bellariastrasse 38, 8038, Zurich, Switzerland
    Urol Res 34:134-8. 2006

Collaborators

  • Yasushi Nakagawa
  • Markus Jaggi
  • Michel Burnier
  • Ljerka Zipperle
  • Peter Greminger
  • Bernard Waeber

Detail Information

Publications5

  1. ncbi Determinants of persistence in hypertensive patients treated with irbesartan: results of a postmarketing survey
    Michel Burnier
    Service de Nephrologie, CHUV, Lausanne, Switzerland
    BMC Cardiovasc Disord 5:13. 2005
    ..The goal of this survey was to evaluate the tolerance and the blood pressure lowering effect of irbesartan as well as the factors affecting persistence in a large unselected population...
  2. ncbi Nutritional aspects of stone disease
    Bernhard Hess
    Departments of Internal Medicine and Nephrology, Hospital Zimmerberg, CH 8820 Waedenswil, Switzerland
    Endocrinol Metab Clin North Am 31:1017-30, ix-x. 2002
    ..This article reviews the current evidence-based knowledge of the impact of nutrition on the recurrence of a kidney stone...
  3. ncbi [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi]
    B Hess
    Medizinische Klinik, Spital Zimmerberg, Wädenswil
    Ther Umsch 60:79-87. 2003
    ..0005)...
  4. ncbi Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function
    Markus Jaggi
    Renal Stone Clinic and Stone Research Laboratory, Policlinic of Internal Medicine, University Hospital, Berne, Switzerland
    Urol Res 35:55-62. 2007
    ..Such increasingly aggregated THP molecules predispose to exaggerated calcium oxalate crystal aggregation, an important prerequisite for urinary stone formation...
  5. ncbi Acid-base metabolism: implications for kidney stones formation
    Bernhard Hess
    Internal Medicine and Nephrology, Klinik Im Park, Bellariastrasse 38, 8038, Zurich, Switzerland
    Urol Res 34:134-8. 2006
    ..e., alkali. In the dRTA, alkali is needed for improving the body's buffer capacity, whereas the goal of alkali treatment in uric acid stone formers is to increase the urinary pH to 6.2-6.8 in order to minimize uric acid crystallization...